肝细胞癌选择性内放射治疗中99mTc-MAA SPECT与90Y微球PET剂量学的差异分析
结果显示归一化后两种方法在肿瘤和正常肝脏的剂量指标上高度相关且一致,但导管尖端位置可重复性显著影响预测与实际剂量分布的符合度。
要点
- 归一化后99mTc-MAA SPECT预测剂量与90Y PET治疗后剂量高度相关一致。
- 导管位置一致时肿瘤平均剂量偏差低于位置不同时(16 Gy vs 37 Gy,P=0.007)。
- 预测与治疗后等剂量线Dice相似系数与导管尖端距动脉分叉距离显著相关。
核心结论
- 计划活度与90Y PET实测活度存在差异,主要与临床操作风险和設備问题有关。
- 归一化后99mTc-MAA SPECT/CT剂量学对90Y微球PET剂量学具有良好预测价值。
- 导管尖端位置的可重复性对预测剂量与实际剂量分布的一致性至关重要。
研究设计与样本
- 基于99mTc-MAA SPECT/CT计算预测剂量学,基于90Y微球PET/CT计算治疗后剂量学,均在体素水平进行。
- 通过平均剂量、剂量体积直方图指标及等剂量线Dice相似系数分析剂量分布。
- 评估放射学操作的可重复性及其对剂量偏差的影响。
主要发现
- 67%(16/24)的病例90Y实际输送活度低于预期,主要由于残留活度。
- 输送活度与90Y PET视野活度之间平均偏差为-6±11%。
- 90Y PET图像上肝脏活度与全视野活度之间平均差异为-20±8%。
- 归一化后99mTc-MAA SPECT与90Y PET剂量学在所有评估的剂量指标上高度相关且一致(肿瘤和正常肝脏平均剂量示例:ρ=0.87,ρc=0.86,P=3.10-8;ρ=0.91,ρc=0.90,P=7.10-10)。
- 导管位置一致时肿瘤平均剂量偏差低于位置不同时(16 Gy vs 37 Gy,P=0.007)。
临床怎么用
- 99mTc-MAA SPECT/CT可用于90Y微球治疗前的剂量预测,但需注意活度输送偏差。
- 操作中应尽量保持导管尖端位置一致,以提高预测剂量与实际剂量分布的符合度。
- 对于导管位置距动脉分叉较远的病例,预测剂量与治疗后剂量分布的一致性可能降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to compare predictive and post-treatment dosimetry and analyze the differences, investigating factors related to activity preparation and delivery, imaging modality used, and interventional radiology. METHODS: Twenty-three HCC patients treated by selective internal radiation therapy with 90Y glass microspheres were included in this study. Predictive and post-treatment dosimetry were calculated at the voxel level based on 99mTc-MAA SPECT/CT and 90Y-microsphere PET/CT respectively. Dose distribution was analyzed through mean dose, metrics extracted from dose-volume histograms, and Dice similarity coefficients applied on isodoses. Reproducibility of the radiological gesture and its influence on dose deviation was evaluated. RESULTS: 90Y delivered activity was lower than expected in 67% (16/24) of the cases mainly due to the residual activity. A mean deviation of - 6 ± 11% was observed between the delivered activity and the 90Y PET's FOV activity. In addition, a substantial difference of - 20 ± 8% was measured on 90Y PET images between the activity in the liver and in the whole FOV. After normalization, 99mTc-MAA SPECT dosimetry was highly correlated and concordant with 90Y-microsphere PET dosimetry for all dose metrics evaluated (ρ = 0.87, ρc = 0.86, P = 3.10-8 and ρ = 0.91, ρc = 0.90, P = 7.10-10 for tumor and normal liver mean dose respectively for example). Besides, mean tumor dose deviation was lower when the catheter position was identical than when it differed (16 Gy vs. 37 Gy, P = 0.007). Concordance between predictive and post-treatment dosimetry, evaluated with Dice similarity coefficients applied on isodoses, significantly correlated with the distance of the catheter position from artery bifurcation (P = 0.04, 0.0004, and 0.05, for 50 Gy, 100 Gy, and 150 Gy isodoses respectively). CONCLUSIONS: Discrepancies between planned activity and activity measured on 90Y PET images were observed and seemed to be mainly related to clinical hazards and equipment issues. Predictive vs. post-treatment comparison of relative dose distributions between tumor and normal liver showed a good correlation and no significant difference highlighting the predictive value of 99mTc MAA SPECT/CT-based dosimetry. Besides, the reproducibility of catheter tip position appears critical in the agreement between predictive and actual dose distribution.
引用
- Kafrouni M, Allimant C, Fourcade M, et al. Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy. EJNMMI Res. 2019. PMID: 31332585. doi:10.1186/s13550-019-0533-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。